|
Real-time Estimate
Cboe Europe
09:33:12 10/03/2026 GMT
|
5-day change
|
1st Jan Change
|
|
254.20 DKK
|
-0.12%
|
 |
+9.87%
|
-21.80%
|
| 05:39am |
TD Cowen downgrades Novo Nordisk to hold (buy), price target 270 Danish kroner - BN
|
FW
| |
03-09 |
Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB…
|  | |
03-09 |
NOVO NORDISK : JP Morgan gives a Neutral rating
|
ZD
| |
03-06 |
NOVO NORDISK : Barclays reaffirms its Neutral rating
|
ZD
| |
03-03 |
Morgan Stanley Upgrades Novo Nordisk to Equalweight From Underweight, Adjusts Price Target to $40 From $42
|
MT
| |
03-03 |
Morgan Stanley Upgrades Novo Nordisk After Share Price Plunge, Sees More Balanced Valuation
|
FW
| |
03-03 |
NOVO NORDISK : Barclays remains Neutral
|
ZD
| |
03-03 |
DNB Carnegie Lowers Price Target for Novo Nordisk to 420 Danish Kroner (430), Reiterates Buy
|
FW
| |
03-03 |
Morgan Stanley Upgrades Novo Nordisk to Equal Weight (from Underweight), Sets Price Target at 250 Danish Kroner - BN
|
FW
| |
03-02 |
Global markets live: Amazon, AWS, Lufthansa, Saudi Aramco, Standard Chartered…
| | |
03-02 |
Goldman Sachs Downgrades Novo Nordisk to Neutral From Buy, Adjusts PT to $41 From $63
|
MT
| |
03-02 |
Goldman Sachs Downgrades Novo Nordisk to Neutral, Cuts PT
|
MT
| |
03-02 |
Goldman Sachs Drops Buy Recommendation on Novo Nordisk Following Study Data
|
FW
| |
03-02 |
NOVO NORDISK : Goldman Sachs is less optimistic
|
ZD
| |
03-02 |
Goldman Sachs Downgrades Novo Nordisk to Neutral (Buy), Sets Price Target at 260 Danish Kroner - BN
|
FW
| |
02-27 |
NOVO NORDISK : Barclays remains Neutral
|
ZD
| |
02-26 |
Aktiespararna Downgrades Novo Nordisk to Hold - No Immediate Turnaround in Sight
|
FW
| |
02-26 |
Analyst recommendations: Spotify, Gartner, Godaddy, Medline, Moderna…
| | |
02-25 |
Kepler Cheuvreux Downgrades Novo Nordisk to Hold Rating, Cuts PT
|
MT
| |
02-24 |
JPMorgan Downgrades Novo Nordisk to Neutral, Cuts PT
|
MT
| |
02-24 |
Jyske Bank Downgrades Novo Nordisk to Hold, Cuts PT
|
MT
| |
02-24 |
JPM Downgrades Novo Nordisk - Expects More Challenging Uptake for Cagrisema
|
FW
| |
02-24 |
NOVO NORDISK : JP Morgan reaffirms its Neutral rating
|
ZD
| |
02-24 |
NOVO NORDISK : Receives a Buy rating from Goldman Sachs
|
ZD
| |
02-24 |
Analysts Lower Recommendations and Price Targets for Novo Nordisk as Shares Continue to Slide
|
FW
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
